Periodic Reporting for period 1 - ENDOTARGET (Systemic Endotoxemia as the driver of chronic inflammation - Biomarkers and novel therapeutic targets for Arthritis)

Rheumatic diseases (RDs) and musculoskeletal disorders affect more than 40% of the European population, causing significant disability, pain, reduced life expectancy and a very high economic burden of around 240 billion euros per year. The available therapies focus on...